989
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Feasibility of dialectical behavior therapy skills training as an outpatient program in treating alcohol use disorder: The role of difficulties with emotion regulation and experiential avoidance

, , , , &
Pages 103-115 | Received 12 Sep 2018, Accepted 01 Mar 2019, Published online: 11 Apr 2019

References

  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
  • American Psychological Association. 2018. Ethical principles of psychologists and code of conduct. http://www.apa.org/ethics/code/.
  • Associazione Italiana di Psicologia: Codice Etico per la Ricerca in Psicologia. 2018. http://www.aipass.org/node/26.
  • A-Tjak JG, Davis ML, Morina N, Powers MB, Smits JA, Emmelkamp PM. 2015. A meta-analysis of the efficacy of acceptance and commitment therapy for clinically relevant mental and physical health problems. Psychother Psychosom. 84(1):30–36.
  • Axelrod SR, Perepletchikova F, Holtzman K, Sinha R. 2011. Emotion regulation and substance use frequency in women with substance dependence and borderline personality disorder receiving dialectical behavior therapy. Am J Drug Alcohol Abuse. 37(1):37–42.
  • Azizi A, Borjali A, Golzari M. 2010. The effectiveness of emotion regulation training and cognitive therapy on the emotional and addictional problems of substance abusers. Iran J Psychiatry. 5(2):60–65.
  • Beckstead DJ, Lambert MJ, DuBose AP, Linehan M. 2015. Dialectical behavior therapy with American Indian/Alaska Native adolescents diagnosed with substance use disorders: combining an evidence based treatment with cultural, traditional, and spiritual beliefs. Addict Behav. 51:84–87.
  • Berking M, Margraf M, Ebert D, Wupperman P, Hofmann SG, Junghanns K. 2011. Deficits in emotion-regulation skills predict alcohol use during and after cognitive–behavioral therapy for alcohol dependence. J Consul Clin Psychol. 79(3):307–318.
  • Berking M, Neacsiu A, Comtois KA, Linehan MM. 2009. The impact of experiential avoidance on the reduction of depression in treatment for borderline personality disorder. Behav Res Ther. 47(8):663–670.
  • Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, Waltz T, Zettle RD. 2011. Preliminary psychometric properties of the Acceptance and Action Questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 42(4):676–688.
  • Bordieri MJ, Tull MT, McDermott MJ, Gratz KL. 2014. The moderating role of experiential avoidance in the relationship between posttraumatic stress disorder symptom severity and cannabis dependence. J Contextual Behav Sci. 3(4):273–278.
  • Borenstein M, Hedges LV, Higgins JP, Rothstein HR. 2011. Introduction to meta-analysis. Chichester: John Wiley & Sons.
  • Bornovalova MA, Daughters SB. 2007. How does dialectical behavior therapy facilitate treatment retention among individuals with comorbid borderline personality disorder and substance use disorders? Clinical Psychology Review. 27(8):923–943.
  • Boulanger JL, Hayes SC, Pistorello J. 2010. Experiential avoidance as a functional contextual concept. In: Kring AM, Sloan DM, editors. Emotion regulation and psychopathology: a transdiagnostic approach to etiology and treatment. New York (NY): The Guilford Press. p. 107–136.
  • Bowen S, Chawla N, Collins SE, Witkiewitz K, Hsu S, Grow J, Clifasefi S, Garner M, Douglass A, Larimer ME, et al. 2009. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Substance Abuse. 30(4):295–305.
  • Bowen S, Witkiewitz K, Dillworth TM, Chawla N, Simpson TL, Ostafin BD, Larimer ME, Blume AW, Parks GA, Marlatt GA. 2006. Mindfulness meditation and substance use in an incarcerated population. Psychol Addict Behav. 20(3):343–347.
  • Brorson HH, Arnevik EA, Rand-Hendriksen K, Duckert F. 2013. Drop-out from addiction treatment: a systematic review of risk factors. Clin Psychol Rev. 33(8):1010–1024.
  • Buckner JD, Zvolensky MJ, Farris SG, Hogan J. 2014. Social anxiety and coping motives for cannabis use: The impact of experiential avoidance. Psychol Addict Behav. 28(2):568–574.
  • Burke BL, Arkowitz H, Menchola M. 2003. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 71(5):843–861.
  • Callaghan RC, Hathaway A, Cunningham JA, Vettese LC, Wyatt S, Taylor L. 2005. Does stage-of-change predict dropout in a culturally diverse sample of adolescents admitted to inpatient substance-abuse treatment? A test of the Transtheoretical Model. Addict Behav. 30(9):1834–1847.
  • Campbell TS, Labelle LE, Bacon SL, Faris P, Carlson LE. 2012. Impact of mindfulness-based stress reduction (MBSR) on attention, rumination and resting blood pressure in women with cancer: a waitlist-controlled study. J Behav Med. 35(3):262–271.
  • Cavicchioli M, Movalli M, Maffei C. 2018. The clinical efficacy of mindfulness-based treatments for alcohol and drugs use disorders: a meta-analytic review of randomized and nonrandomized controlled trials. Eur Addict Res. 24(3):137–162.
  • Cavicchioli M, Movalli M, Maffei C. 2019. Difficulties with emotion regulation, mindfulness, and substance use disorder severity: the mediating role of self-regulation of attention and acceptance attitudes. Am J Drug Alcohol Abuse. 45(1):97–107.
  • Cavicchioli M, Rugi C, Maffei C. 2015. Inability to withstand present-moment experiences in borderline personality disorder: a meta-analytic review. Clin Neuropsychiatry. 12(4):101–110.
  • Chambers R, Gullone E, Allen NB. 2009. Mindful emotion regulation: an integrative review. Clin Psychol Rev. 29(6):560–572.
  • Chapman AL. 2006. Dialectical behavior therapy: current indications and unique elements. Psychiatry (Edgmont). 3(9):62–68.
  • Chapman AL, Dixon-Gordon KL, Walters KN. 2011. Experiential avoidance and emotion regulation in borderline personality disorder. J Rat-Emo Cognit-Behav Ther. 29(1):35–52.
  • Chapman AL, Gratz KL, Brown MZ. 2006. Solving the puzzle of deliberate self-harm: the experiential avoidance model. Behav Res Ther. 44(3):371–394.
  • Chawla N, Ostafin B. 2007. Experiential avoidance as a functional dimensional approach to psychopathology: an empirical review. J Clin Psychol. 63(9):871–890.
  • Cheetham A, Allen NB, Yücel M, Lubman DI. 2010. The role of affective dysregulation in drug addiction. Clin Psychol Rev. 30(6):621–634.
  • Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. 2006. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol. 11(Pt 3):421–437.
  • Comtois KA, Koons CR, Kim SA, Manning SY, Bellows E, Dimeff LA. 2007. Implementing standard dialectical behavior therapy in an outpatient setting. In: Dimeff LA, Koerner K, editors. Dialectical behavior therapy in clinical practice: applications across disorders and settings. New York (NY): Guilford Press; p. 37–68.
  • Cone EJ, Tsadik A, Oyler J, Darwin WD. 1998. Cocaine metabolism and urinary excretion after different routes of administration. Therapeut Drug Monit. 20(5):556–560.
  • Consoli A, Bennardo A. 2001. Diagnosi e valutazione nelle tossicodipendenze e nell’alcolismo: addiction severity index. Torino: Centro Scientifico Editore.
  • Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. 2017. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 74(4):319–328.
  • Curry S, Marlatt GA, Gordon JR. 1987. Abstinence violation effect: validation of an attributional construct with smoking cessation. J Consult Clin Psychol. 55(2):145–149.
  • Davison AC. 1997. Bootstrap methods and their application. Vol. 1. New York (NY): Cambridge University Press.
  • de Sola LLopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K. 2008. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study. J Psychopharmacol. 22(5):498–510.
  • DeCou CR, Comtois KA, Landes SJ. 2019. Dialectical behavior therapy is effective for the treatment of suicidal behavior: a meta-analysis. Behav Ther. 50:60–72.
  • Dimeff LA, Linehan MM. 2008. Dialectical behavior therapy for substance abusers. ASCP. 4(2):39–47.
  • Dimeff LA, Marlatt GA. 1995. Relapse prevention. In Hester R, Miller WR, editors. Handbook of alcoholism treatment approaches. 2nd ed. Needham Heights (MA): Allyn & Bacon; pp. 176–194.
  • Dimeff L, Rizvi SL, Brown M, Linehan MM. 2000. Dialectical behavior therapy for substance abuse: a pilot application to methamphetamine-dependent women with borderline personality disorder. Cogn Behav Pract. 7(4):457–468.
  • Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. 2008. A meta-analytic review of psychosocial interventions for substance use disorders. AJP. 165(2):179–187.
  • Ferri M, Amato L, Davoli M. 2006. Alcoholics anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev. (3):CD005032.
  • Forsyth JP, Parker JD, Finlay CG. 2003. Anxiety sensitivity, controllability, and experiential avoidance and their relation to drug of choice and addiction severity in a residential sample of substance-abusing veterans. Addict Behav. 28(5):851–870.
  • Fox HC, Hong KA, Sinha R. 2008. Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers. Addict Behav. 33(2):388–394.
  • Gámez W, Chmielewski M, Kotov R, Ruggero C, Suzuki N, Watson D. 2014. The brief experiential avoidance questionnaire: development and initial validation. Psychol Assess. 26(1):35.
  • Gámez W, Chmielewski M, Kotov R, Ruggero C, Watson D. 2011. Development of a measure of experiential avoidance: the multidimensional experiential avoidance questionnaire. Psychol Assess. 23(3):692–713.
  • Giromini L, Velotti P, de Campora G, Bonalume L, Cesare Zavattini G. 2012. Cultural adaptation of the difficulties in emotion regulation scale: reliability and validity of an Italian version. J Clin Psychol. 68(9):989–1007.
  • Govaerts MJ, Schuwirth LWT, Van der Vleuten CPM, Muijtjens AMM. 2011. Workplace-based assessment: effects of rater expertise. Adv in Health Sci Educ. 16(2):151–165.
  • Gratz KL, Roemer L. 2004. Multidimensional assessment of emotion regulation and dysregulation: Development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 26(1):41–54.
  • Gratz KL, Weiss NH, Tull MT. 2015. Examining emotion regulation as an outcome, mechanism, or target of psychological treatments. Curr Opin Psychol. 3:85–90.
  • Gross JJ. 1998. The emerging field of emotion regulation: an integrative review. Rev Gen Psychol. 2(3):271.
  • Harned MS, Chapman AL, Dexter-Mazza ET, Murray A, Comtois KA, Linehan MM. 2008. Treating cooccurring Axis I disorders in recurrently suicidal women with borderline personality disorder: A 2-year randomized trial of dialectical behavior therapy versus community treatment by experts. J Consult Clin Psychol. 76(6):1068–1075.
  • Hayes AF. 2017. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. New York: Guilford Press.
  • Hayes SC, Strosahl K, Wilson KG, Bissett RT, Pistorello J, Toarmino D, Polusny MA, Dykstra TA, Batten SV, Bergan J. 2004. Measuring experiential avoidance: a preliminary test of a working model. Psychol Rec. 54(4):553–578.
  • Hayes SC, Wilson KG, Gifford EV, Follette VM, Strosahl K. 1996. Experiential avoidance and behavioral disorders: a functional dimensional approach to diagnosis and treatment. J Consult Clin Psychol. 64(6):1152–1168.
  • Hedberg EC, Ayers S. 2015. The power of a paired t-test with a covariate. Soc Sci Res. 50:277–291.
  • Helander A, Böttcher M, Fehr C, Dahmen N, Beck O. 2008. Detection times for urinary ethyl glucuronide and ethyl sulfate in heavy drinkers during alcohol detoxification. Alcohol Alcohol. 44(1):55–61.
  • Hofmann SG, Asmundson GJ. 2008. Acceptance and mindfulness-based therapy: new wave or old hat? Clin Psychol Rev. 28(1):1–16.
  • Hollis S, Campbell F. 1999. What is meant by intention to treat analysis? Survey of published randomised controlled trials. Brit Med J. 319(7211):670–674.
  • Hooper N, Villatte M, Neofotistou E, McHugh L. 2010. The effects of mindfulness versus thought suppression on implicit and explicit measures of experiential avoidance. Int J Behav Consult Ther. 6(3):233–244.
  • Iverson KM, Follette VM, Pistorello J, Fruzzetti AE. 2012. An investigation of experiential avoidance, emotion dysregulation, and distress tolerance in young adult outpatients with borderline personality disorder symptoms. Personal Disord. 3(4):415–422.
  • John OP, Donahue EM, Kentle RL. 1991. The big five inventory—versions 4a and 54. Berkeley, CA: Berkeley Institute of Personality and Social Research, University of California.
  • Kadden RM, Litt MD. 2011. The role of self-efficacy in the treatment of substance use disorders. Addict Behav. 36(12):1120–1126.
  • Karekla M, Panayiotou G. 2011. Coping and experiential avoidance: unique or overlapping constructs? J Behav Ther Exp Psychiatry. 42(2):163–170.
  • Kashdan TB, Barrios V, Forsyth JP, Steger MF. 2006. Experiential avoidance as a generalized psychological vulnerability: comparisons with coping and emotion regulation strategies. Behav Res Therapy. 44(9):1301–1320.
  • Kashdan TB, Rottenberg J. 2010. Psychological flexibility as a fundamental aspect of health. Clin Psychol Rev. 30(7):865–878.
  • Kienast T, Stoffers J, Bermpohl F, &Lieb K. 2014. Borderline personality disorder and comorbid addiction: epidemiology and treatment. DeutschesÄrzteblatt Int. 111(16):280–286.
  • Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. 2004. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Ther Drug Monit. 26(6):664–672.
  • Kingston J, Clarke S, Remington B. 2010. Experiential avoidance and problem behavior: a mediational analysis. Behav Modif. 34(2):145–163.
  • Kokkevi A, Hartgers C. 1995. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Eur Addict Res. 1(4):208–210.
  • Larimer ME, Palmer RS, Marlatt GA. 1999. Relapse prevention: an overview of Marlatt’s cognitive-behavioral model. Alcohol Res Health. 23(2):151–160.
  • Levin ME, Lillis J, Seeley J, Hayes SC, Pistorello J, Biglan A. 2012. Exploring the relationship between experiential avoidance, alcohol use disorders, and alcohol-related problems among first-year college students. J Am Coll Health. 60(6):443–448.
  • Linehan MM. 1981. A social-behavioral analysis of suicide and parasuicide: implications for clinical assessment and treatment. In: Glazer H, Clarkin JF, editors. Depression, behavioral and directive intervention strategies. New York: Garland Press; p. 229–294.
  • Linehan MM. 1993. Cognitive-behavioral treatment of borderline personality disorder. New York: Guilford.
  • Linehan MM. 2014. DBT skills training manual. New York: Guilford
  • Linehan MM, Dimeff LA, Reynolds SK, Comtois KA, Welch SS, Heagerty P, Kivlahan DR. 2002. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend. 67(1):13–26.
  • Linehan MM, Schmidt H, Dimeff LA, Craft JC, Kanter J, Comtois KA. 1999. Dialectical behavior therapy for patients with borderline personality disorder and drugdependence. Am J Addict. 8(4):279–292.
  • Linehan MM, Wilks CR. 2015. The course and evolution of dialectical behavior therapy. Am J Psychother. 69(2):97–110.
  • Luberto CM, Cotton S, McLeish AC, Mingione CJ, O’Bryan EM. 2014. Mindfulness skills and emotion regulation: The mediating role of coping self-efficacy. Mindfulness. 5(4):373–380.
  • Machell KA, Goodman FR, Kashdan TB. 2015. Experiential avoidance and well-being: a daily diary analysis. Cogn Emot. 29(2):351–359.
  • Maffei C, Cavicchioli M, Movalli M, Cavallaro R, Fossati A. 2018. Dialectical behavior therapy skills training in alcohol dependence treatment: findings based on an open trial. Subst Use Misuse. 53(14):2368–2385.
  • Mann K, Bladström A, Torup L, Gual A, van den Brink W. 2013. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene. Biol Psychiatry. 73(8):706–713.
  • Marlatt GA, Donovan DM. 2005. Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford.
  • Marlatt GA, Gordon JR. 1985. Relapse prevention. New York: Guilford Press
  • Martin CS, Kaczynski NA, Maisto SA, Tarter RE. 1996. Polydrug use in adolescent drinkers with and without DSM‐IV alcohol abuse and dependence. Alcohol Clin Exp Res. 20(6):1099–1108.
  • McGahan PL, Griffith JA, Parente R, McLellann AT. 1986. Composite scores manual.
  • McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. 1992. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat. 9(3):199–213.
  • McMain S, Sayrs JHR, Dimeff LA, Linehan MM. 2007. Dialectical behavior therapy for individuals with borderline personality disorder and substance dependence. In: Dimeff, LA, Koerner KE, editors. Dialectical behavior therapy in clinical practice: applications across disorders and settings. New York: Guilford; p. 145–173.
  • Montori VM, Guyatt GH. 2001. Intention-to-treat principle. Canad Med Assoc J. 165(10):1339–1341.
  • Musshoff F, Madea B. 2006. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit. 28(2):155–163.
  • Neacsiu AD, Eberle JW, Kramer R, Wiesmann T, Linehan MM. 2014a. Dialectical behavior therapy skills for transdiagnostic emotion dysregulation: a pilot randomized controlled trial. Behav Res Ther. 59:40–51.
  • Neacsiu AD, Lungu A, Harned MS, Rizvi SL, Linehan MM. 2014b. Impact of dialectical behavior therapy versus community treatment by experts on emotional experience, expression, and acceptance in borderline personality disorder. Behav Res Ther. 53:47–54.
  • Neacsiu AD, Rizvi SL, Linehan MM. 2010. Dialectical behavior therapy skills use as a mediator and outcome of treatment for borderline personality disorder. Behav Res Ther. 48(9):832–839.
  • Neacsiu AD, Rizvi SL, Vitaliano PP, Lynch TR, Linehan MM. 2010. The dialectical behavior therapy ways of coping checklist: development and psychometric properties. J Clin Psychol. 66(6):563–582.
  • O’Malley SS, O’Connor PG. 2011. Medications for unhealthy alcohol use: across the spectrum. Alcohol Res Health. 33(4):300–312.
  • Pennato T, Berrocal C, Bernini O, Rivas T. 2013. Italian version of the Acceptance and Action Questionnaire-II (AAQ-II): dimensionality, reliability, convergent and criterion validity. J Psychopathol Behav Assess. 35(4):552–563.
  • Perroud N, Nicastro R, Jermann F, Huguelet P. 2012. Mindfulness skills in borderline personality disorder patients during dialectical behavior therapy: preliminary results. Int J Psychiatry Clin Pract. 16(3):189–196.
  • Prendergast M, Podus D, Finney J, Greenwell L, Roll J. 2006. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction. 101(11):1546–1560.
  • Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. 2002. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol. 26(7):393–400.
  • Rizvi SL, Dimeff LA, Skutch J, Carroll D, Linehan MM. 2011. A pilot study of the DBT coach: an interactive mobile phone application for individuals with borderline personality disorder and substance use disorder. Behav Ther. 42(4):589–600.
  • Rochefort C, Baldwin AS, Chmielewski M. 2018. Experiential avoidance: an examination of the construct validity of the aaq-ii and meaq. Behav Ther. 49(3):435–449.
  • Rüsch N, Schiel S, Corrigan PW, Leihener F, Jacob GA, Olschewski M, Lieb K, Bohus M. 2008. Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder. J Behav Ther Exp Psychiatry. 39(4):497–503.
  • Shallcross AJ, Troy AS, Boland M, Mauss IB. 2010. Let it be: accepting negative emotional experiences predicts decreased negative affect and depressive symptoms. Behav Res Ther. 48(9):921–929.
  • Shorey RC, Gawrysiak MJ, Elmquist J, Brem M, Anderson S, Stuart GL. 2017. Experiential avoidance, distress tolerance, and substance use cravings among adults in residential treatment for substance use disorders. J Addict Dis. 36:151–157.
  • Sloan DM. 2004. Emotion regulation in action: Emotional reactivity in experiential avoidance. Behav Res Ther. 42(11):1257–1270.
  • Stepp SD, Epler AJ, Jahng S, Trull TJ. 2008. The effect of dialectical behavior therapy skills use on borderline personality disorder features. J Pers Disord. 22(6):549–563.
  • Stevens L, Verdejo-García A, Roeyers H, Goudriaan AE, Vanderplasschen W. 2015. Delay discounting, treatment motivation and treatment retention among substance-dependent individuals attending an in inpatient detoxification program. J Subst Abuse Treat. 49:58–64.
  • Tenore PL. 2010. Advanced urine toxicology testing. J Addict Dis. 29(4):436–448.
  • Tyndall I, Waldeck D, Pancani L, Whelan R, Roche B, Dawson DL. 2018. The Acceptance and Action Questionnaire-II (AAQ-II) as a measure of experiential avoidance: concerns over discriminant validity. J Contextual Behav Sci. http://dx.doi.org/10.1016/j.jcbs.2018.09.005
  • Valentine SE, Bankoff SM, Poulin RM, Reidler EB, Pantalone DW. 2015. The use of dialectical behavior therapy skills training as stand‐alone treatment: a systematic review of the treatment outcome literature. J Clin Psychol. 71(1):1–20.
  • van den Bosch LM, Verheul R, Schippers GM, van den Brink W. 2002. Dialectical behavior therapy of borderline patients with and without substance use problems: implementation and long-term effects. Addict Behav. 27(6):911–923.
  • Watson D, Clark LA, Tellegen A. 1988. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Personal Soc Psychol. 54(6):1063–1070.
  • Werner KH, Goldin PR, Ball TM, Heimberg RG, Gross JJ. 2011. Assessing emotion regulation in social anxiety disorder: The emotion regulation interview. J Psychopathol Behav Assess. 33(3):346–354.
  • Witkiewitz K, Marlatt GA, Walker D. 2005. Mindfulness-based relapse prevention for alcohol and substance use disorders. J Cogn Psychother. 19(3):211–228.
  • Wolgast M. 2014. What does the Acceptance and Action Questionnaire (AAQ-II) really measure? Behav Ther. 45(6):831–839.
  • Wurst FM, Kempter C, Seidl S, Alt A. 1999. Ethyl glucuronide–a marker of alcohol consumption and a relapse marker with clinical and forensic implications. Alcohol Alcohol. 34(1):71–77.
  • Zvolensky MJ, Vujanovic AA, Bernstein A, Leyro T. 2010. Distress tolerance: theory, measurement, and relations to psychopathology. Curr Dir Psychol Sci. 19(6):406–410.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.